Vergori, Alessandra;
Cozzi-Lepri, Alessandro;
Matusali, Giulia;
Colavita, Francesca;
Cicalini, Stefania;
Gallì, Paola;
Garbuglia, Anna Rosa;
... Antinori, Andrea; + view all
(2022)
SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH.
Viruses
, 14
(8)
, Article 1710. 10.3390/v14081710.
Preview |
Text
viruses-14-01710.pdf - Published Version Download (552kB) | Preview |
Abstract
The aim was to measure neutralizing antibody levels against the SARS-CoV-2 Omicron (BA.1) variant in serum samples obtained from vaccinated PLWH and healthcare workers (HCW) and compare them with those against the Wuhan-D614G (W-D614G) strain, before and after the third dose of a mRNA vaccine. We included 106 PLWH and 28 HCWs, for a total of 134 participants. Before the third dose, the proportion of participants with undetectable nAbsT against BA.1 was 88% in the PLWH low CD4 nadir group, 80% in the high nadir group and 100% in the HCW. Before the third dose, the proportion of participants with detectable nAbsT against BA.1 was 12% in the PLWH low nadir group, 20% in the high nadir group and 0% in HCW, respectively. After 2 weeks from the third dose, 89% of the PLWH in the low nadir group, 100% in the high nadir group and 96% of HCW elicited detectable nAbsT against BA.1. After the third dose, the mean log2 nAbsT against BA.1 in the HCW and PLWH with a high nadir group was lower than that seen against W-D614G (6.1 log2 (±1.8) vs. 7.9 (±1.1) and 6.4 (±1.3) vs. 8.6 (±0.8)), respectively. We found no evidence of a different level of nAbsT neutralization by BA.1 vs. W-D614G between PLWH with a high CD4 nadir and HCW (0.40 (−1.64, 2.43); p = 0.703). Interestingly, in PLWH with a low CD4 nadir, the mean log2 difference between nAbsT against BA.1 and W-D614G was smaller in those with current CD4 counts 201–500 vs. those with CD4 counts < 200 cells/mm3 (−0.80 (−1.52, −0.08); p = 0.029), suggesting that in this target population with a low CD4 nadir, current CD4 count might play a role in diversifying the level of SARS-CoV-2 neutralization.
| Type: | Article |
|---|---|
| Title: | SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.3390/v14081710 |
| Publisher version: | https://doi.org/10.3390/v14081710 |
| Language: | English |
| Additional information: | © 2022 MDPI. This is an open access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). |
| Keywords: | SARS-CoV-2; HIV/AIDS; SARS-CoV-2 vaccine; Omicron variant; neutralization titers; third dose vaccine |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10153546 |
Archive Staff Only
 |
View Item |
